학술논문
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation
Document Type
article
Author
Tamari, Roni; Oran, Betul; Hilden, Patrick; Maloy, Molly; Kongtim, Piyanuch; Papadopoulos, Esperanza B; Rondon, Gabriela; Jakubowski, Ann A; Andersson, Borje S; Devlin, Sean M; Ahmed, Sairah; Popat, Uday R; Ponce, Doris; Chen, Julianne; Sauter, Craig; Young, James W; de Lima, Marcos; Perales, Miguel-Angel; O'Reilly, Richard J; Giralt, Sergio A; Champlin, Richard E; Castro-Malaspina, Hugo
Source
Transplantation and Cellular Therapy. 24(5)
Subject
Language
Abstract
In this study, we compared transplantation outcomes of allogeneic hematopoietic stem cell transplantation (HSCT) in patients with advanced myelodysplastic syndrome (MDS) who received a CD34+ cell-selected and those who received an unmodified allograft. This analysis initially included 181 patients, 60 who received a CD34+ cell-selected transplant and 121 who received an unmodified transplant. Owing to significant differences in disease characteristics, the analysis was limited to patients with